Alan Brochstein
shared:
6/9/2017 8:08:53 AM
ReplyThe 420 Investor On MedReleaf's Rough IPO: The Stock Is Still A 'Screaming Buy' https://t.co/6xlDq9Hoix $LEAF $TWMJF via @benzinga
— Alan Brochstein, CFA (@Invest420) June 9, 2017
